SCHEMBL25355779

SCHEMBL25355779

NC(Cc1ccc(C(=O)O)nc1)C(=O)O

nearest known ligand 0.57

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
P4HTM Q9NXG6 5/20 0.57
HSD17B10 Q99714 2/20 0.57
SLC7A5 Q01650 3/20 0.54
PKM P14618 3/20 0.53
PTGS1 P23219 2/20 0.53
ALPI P09923 1/20 0.53
XIAP P98170 1/20 0.53
KDM4E B2RXH2 2/20 0.51
ALOX15 P16050 2/20 0.51
HIF1A Q16665 2/20 0.51
TDP1 Q9NUW8 2/20 0.51
MEN1 O00255 1/20 0.51
ALDH1A1 P00352 1/20 0.51
LMNA P02545 1/20 0.51
CYP1A2 P05177 1/20 0.51
CYP3A4 P08684 1/20 0.51
MAPT P10636 1/20 0.51
TSHR P16473 1/20 0.51
NFKB1 P19838 1/20 0.51
THPO P40225 1/20 0.51

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL31303980 1.00 P4HTM (0.57) P4HTMHSD17B10SLC7A5PKMPTGS1
SCHEMBL26008291 1.00 P4HTM (0.57) P4HTMHSD17B10SLC7A5PKMPTGS1
SCHEMBL31267214 0.89 HSD17B10 (0.55) P4HTMHSD17B10SLC7A5PKMPTGS1
SCHEMBL25357398 0.89 HSD17B10 (0.55) P4HTMHSD17B10SLC7A5PKMPTGS1
SCHEMBL25357394 0.89 HSD17B10 (0.55) P4HTMHSD17B10SLC7A5PKMPTGS1
SCHEMBL26009219 0.89 HSD17B10 (0.55) P4HTMHSD17B10SLC7A5PKMPTGS1
SCHEMBL31267221 0.89 HSD17B10 (0.55) P4HTMHSD17B10SLC7A5PKMPTGS1
SCHEMBL31688576 0.83 SLC7A5 (0.53) HSD17B10SLC7A5PKMPTGS1ALPI
SCHEMBL19704241 0.81 SLC7A5 (0.61) HSD17B10SLC7A5PKMPTGS1ALPI
SCHEMBL15314368 0.81 CPB2 (0.63) HSD17B10SLC7A5PKMPTGS1ALPI

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20230257343-A1 NOVEL AMINO ACID DERIVATIVES PEPTIDREAM INC (JP) 2023-08-17 US claimed
US-20230257343-A1 NOVEL AMINO ACID DERIVATIVES PEPTIDREAM INC (JP) 2023-08-17 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20230257343-A1 NOVEL AMINO ACID DERIVATIVES DNPEP, BCAT1, ANPEP P4HTM 1930/4885HSD17B10 3966/4885SLC7A5 21/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.